The Role of Genetic Polymorphisms in High-Dose Methotrexate Toxicity and Response in Hematological Malignancies: A Systematic Review and Meta-Analysis
Objective: High-dose methotrexate (HDMTX) is a mainstay therapeutic agent for the treatment of diverse hematological malignancies, and it plays a significant role in interindividual variability regarding the pharmacokinetics and toxicity. The genetic association of HDMTX has been widely investigated...
Saved in:
Main Authors: | Zaiwei Song (Author), Yang Hu (Author), Shuang Liu (Author), Dan Jiang (Author), Zhanmiao Yi (Author), Mason M. Benjamin (Author), Rongsheng Zhao (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2021-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Knowledge, Attitudes and Practice of Healthcare Providers, Healthcare Regulatory Practitioners and Patients Toward Biosimilars in China: Insights From a Nationwide Survey
by: Yang Hu, et al.
Published: (2022) -
Toward Therapeutic Drug Monitoring of Lenalidomide in Hematological Malignancy? Results of an Observational Study of the Exposure-Safety Relationship
by: Zaiwei Song, et al.
Published: (2022) -
Optimal Management of the Public and Patients by Pharmacists in the Era of COVID-19: An Evidence-Based Review and Practical Recommendations
by: Zaiwei Song, et al.
Published: (2022) -
Medication adherence and costs of medical care among patients with Parkinson's disease: an observational study using electronic medical records
by: Zhanmiao Yi, et al.
Published: (2024) -
Association between high-dose methotrexate-induced toxicity and polymorphisms within methotrexate pathway genes in acute lymphoblastic leukemia
by: Meng Xu, et al.
Published: (2022)